Cell-free degradation of p27kip1, a G1 cyclin-dependent kinase inhibitor, is dependent on CDK2 activity and the proteasome

被引:0
|
作者
Nguyen, H
Gitig, DM
Koff, A
机构
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] Cornell Univ, Grad Sch Med Sci, Program Mol Biol & Cell Biol & Genet, New York, NY 10021 USA
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Entry into S phase is dependent on the coordinated activation of CDK4,6 and CDK2 kinases. Once a cell commits to S phase, there must be a mechanism to ensure the irreversibility of this decision. The activity of these kinases is inhibited by their association with p27. In many cells, p27 plays a major role in the withdrawal from the cell cycle in response to environmental cues. Thus, ii: is likely that p27 is a target of the machinery required to ensure the irreversibility of S-phase entry. We have been interested in understanding the mechanisms regulating p27 at the G(1)/S transition. In this report, we define a cell-free degradation system which faithfully recapitulates the cell cycle phase-specific degradation of p27. We show that this reaction is dependent on active CDK2 activity, suggesting that CDK2 activity is directly required for p27 degradation, In addition to CDK2, other S-phase-specific factors are required for p27 degradation. ill least some of these factors are ubiquitin and proteasome dependent. We discuss the relationships between CDK2 activity, ubiquitin-dependent, and possibly ubiquitin-independent proteasomal activities in S-phase extracts as related to p27.
引用
收藏
页码:1190 / 1201
页数:12
相关论文
共 50 条
  • [1] Identification of cdk2 binding sites on the p27Kip1 cyclin-dependent kinase inhibitor
    Taeg Kyu Kwon
    Albert A Nordin
    Oncogene, 1998, 16 : 755 - 762
  • [2] Identification of cdk2 binding sites on the p27Kip1 cyclin-dependent kinase inhibitor
    Kwon, TK
    Nordin, AA
    ONCOGENE, 1998, 16 (06) : 755 - 762
  • [3] Modulation of apoptosis by the cyclin-dependent kinase inhibitor p27Kip1
    Hiromura, K
    Pippin, JW
    Fero, ML
    Roberts, JM
    Shankland, SJ
    JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (05): : 597 - 604
  • [4] Pirh2 promotes ubiquitin-dependent degradation of the cyclin-dependent kinase inhibitor p27Kip1
    Hattori, Takayuki
    Isobe, Tomoyasu
    Abe, Kenji
    Kikuchi, Hirotoshi
    Kitagawa, Kyoko
    Oda, Toshiaki
    Uchida, Chiharu
    Kitagawa, Masatoshi
    CANCER RESEARCH, 2007, 67 (22) : 10789 - 10795
  • [5] BRCA1 transactivates the cyclin-dependent kinase inhibitor p27Kip1
    Elizabeth A Williamson
    Farnaz Dadmanesh
    H Phillip Koeffler
    Oncogene, 2002, 21 : 3199 - 3206
  • [6] BRCA1 transactivates the cyclin-dependent kinase inhibitor p27Kip1
    Williamson, EA
    Dadmanesh, F
    Koeffler, HP
    ONCOGENE, 2002, 21 (20) : 3199 - 3206
  • [7] The accumulation of cyclin-dependent kinase inhibitor p27kip1 is a primary response to staurosporine and independent of G1 cell cycle arrest
    Nishi, K
    Schnier, JB
    Bradbury, EM
    EXPERIMENTAL CELL RESEARCH, 1998, 243 (02) : 222 - 231
  • [8] Expression of cyclin-dependent kinase inhibitor p27kip1 in malignant lymphomas
    Oh, YH
    Park, CK
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2000, 15 (04) : 399 - 406
  • [9] Modulation of astrocyte proliferation by cyclin-dependent kinase inhibitor p27Kip1
    Koguchi, K
    Nakatsuji, Y
    Nakayama, K
    Sakoda, S
    GLIA, 2002, 37 (02) : 93 - 104
  • [10] TGFβ prevents proteasomal degradation of the cyclin-dependent kinase inhibitor p27kip1 for cell cycle arrest
    Lecanda, Jon
    Ganapathy, Vidya
    D'Aquino-Ardalan, Christine
    Evans, Brad
    Cadacio, Caprice
    Ayala, Aidee
    Gold, Leslie I.
    CELL CYCLE, 2009, 8 (05) : 742 - 756